During the shortage, less regulated compound pharmacies stepped in to fill the demand for these drugs
This precision-focused approach aligns with PlexusDx's commitment to personalized GLP-1 therapy, ensuring your provider has both genetic and clinical data to optimize your treatment plan
OSA approval: Zepbound became the first GLP-1 drug approved for obstructive sleep apnea in December 2025
Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan
Today, our mission is to restore essential nutrients to the modern human diet - nutrients that are vital for health, balance, and better living
Q., Eastham, C., & Forman, M